JP2019524782A5 - - Google Patents

Download PDF

Info

Publication number
JP2019524782A5
JP2019524782A5 JP2019505490A JP2019505490A JP2019524782A5 JP 2019524782 A5 JP2019524782 A5 JP 2019524782A5 JP 2019505490 A JP2019505490 A JP 2019505490A JP 2019505490 A JP2019505490 A JP 2019505490A JP 2019524782 A5 JP2019524782 A5 JP 2019524782A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
mercaptoethylisophthalamide
nbmi
bis
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019505490A
Other languages
English (en)
Japanese (ja)
Other versions
JP6926192B2 (ja
JP2019524782A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2017/052306 external-priority patent/WO2018025049A1/en
Publication of JP2019524782A publication Critical patent/JP2019524782A/ja
Publication of JP2019524782A5 publication Critical patent/JP2019524782A5/ja
Application granted granted Critical
Publication of JP6926192B2 publication Critical patent/JP6926192B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019505490A 2016-08-05 2017-08-04 N,n−ビス−2−メルカプトエチルイソフタルアミドの新規用途 Active JP6926192B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201613535 2016-08-05
GB1613535.2 2016-08-05
PCT/GB2017/052306 WO2018025049A1 (en) 2016-08-05 2017-08-04 New use of n,n-bis-2-mercaptoethyl isophthalamide

Publications (3)

Publication Number Publication Date
JP2019524782A JP2019524782A (ja) 2019-09-05
JP2019524782A5 true JP2019524782A5 (enExample) 2020-09-10
JP6926192B2 JP6926192B2 (ja) 2021-08-25

Family

ID=60202272

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019505490A Active JP6926192B2 (ja) 2016-08-05 2017-08-04 N,n−ビス−2−メルカプトエチルイソフタルアミドの新規用途

Country Status (32)

Country Link
US (2) US20190240173A1 (enExample)
EP (2) EP4029497A1 (enExample)
JP (1) JP6926192B2 (enExample)
KR (1) KR102538388B1 (enExample)
CN (1) CN109562179A (enExample)
AU (1) AU2017305661B2 (enExample)
BR (1) BR112019002130A2 (enExample)
CA (1) CA3032858A1 (enExample)
CL (1) CL2019000229A1 (enExample)
CY (1) CY1125039T1 (enExample)
DK (1) DK3493849T3 (enExample)
EA (1) EA201990443A1 (enExample)
ES (1) ES2907838T3 (enExample)
HR (1) HRP20220252T1 (enExample)
HU (1) HUE057782T2 (enExample)
IL (1) IL264538B2 (enExample)
LT (1) LT3493849T (enExample)
MA (1) MA45855B1 (enExample)
MD (1) MD3493849T2 (enExample)
MX (1) MX387853B (enExample)
MY (1) MY199733A (enExample)
NZ (1) NZ750271A (enExample)
PH (1) PH12019500237A1 (enExample)
PL (1) PL3493849T3 (enExample)
PT (1) PT3493849T (enExample)
RS (1) RS62924B1 (enExample)
SG (1) SG11201900565RA (enExample)
SI (1) SI3493849T1 (enExample)
SM (1) SMT202200109T1 (enExample)
UA (1) UA125394C2 (enExample)
WO (1) WO2018025049A1 (enExample)
ZA (1) ZA201900594B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202005057D0 (en) 2020-04-06 2020-05-20 Emeramed Ltd New Use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586600B2 (en) 2000-12-06 2003-07-01 University Of Kentucky Research Foundation Multidentate sulfur-containing ligands
US8950583B2 (en) 2008-12-06 2015-02-10 Ermes Medical Company Limited Method to remove heavy metals from a mammal
WO2011006097A2 (en) * 2009-07-10 2011-01-13 The Brigham And Women's Hospital, Inc. Methods For Treating Toxicity
US8575218B2 (en) 2009-09-28 2013-11-05 The University Of Kentucky Research Foundation Thiol-containing compounds for the removal of elements from tissues and formulations therefor
JP2013505963A (ja) 2009-09-28 2013-02-21 ユニヴァーシティ オブ ケンタッキー リサーチ ファウンデイション 汚染された環境から元素を除去するチオール含有化合物およびその使用方法
US20110237776A1 (en) 2010-03-25 2011-09-29 Haley Boyd E Aromatic compounds with sulfur containing ligands
US8426368B2 (en) 2010-03-25 2013-04-23 The University Of Kentucky Research Foundation Method of ameliorating oxidative stress and supplementing the diet

Similar Documents

Publication Publication Date Title
JP2015523407A5 (enExample)
JP2016106150A5 (enExample)
JP2017506624A5 (enExample)
JP2015038135A5 (enExample)
JP2013231087A5 (enExample)
HRP20210749T1 (hr) Farmaceutski pripravci koji sadrže azd9291
JP2019535760A5 (ja) ガボキサドールを用いた注意欠陥多動性障害(adhd)の治療方法
FI3493812T3 (fi) Imetelstaatin ja venetoklaksin yhdistelmiä akuutin myelooisen leukemian hoitoa varten
MA50189A (fr) Formulations pharmaceutiques d'oligomère cyclique et d'abiratérone et procédés de formation et d'administration de celles-ci
JP2013541583A5 (enExample)
JP2013518124A5 (enExample)
JP2017503014A5 (enExample)
JP2017508817A5 (enExample)
EP3400964A4 (en) TASTE-MASKED AND ORAL ADMINISTRATIVE PHARMACEUTICAL PREPARATION WITH VARENICLIN OR PHARMACEUTICAL SALT OF IT
EP4041734C0 (en) DERIVATIVES HAVING A 1,2,3,4-TETRAHYDRONAPHTHALENE FRACTION OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
JP2017507142A5 (enExample)
JP2017512194A5 (enExample)
RU2016127558A (ru) Стероидное соединение для применения в лечении печеночной энцефалопатии
MX385518B (es) FORMULACIÓN QUE TIENE CARACTERÍSTICAS MEJORADAS DE LIBERACIÓN DE FÁRMACOS pH DEPENDIENTES, QUE CONTIENEN ESOMEPRAZOL O UNA DE SUS SALES FARMACÉUTICAS ACEPTABLE.
JP2018521007A5 (enExample)
IL272834B2 (en) Amantadine compositions, preparations thereof, and methods of use
JP2021505669A5 (enExample)
JP2018506533A5 (enExample)
HRP20211661T1 (hr) Igmezin, namijenjen upotrebi u liječenju alzheimerove bolesti
JP2019524782A5 (enExample)